Found: 24
Select item for more details and to access through your institution.
Neoadjuvant talazoparib in patients with germline BRCA1/2 mutation-positive, early-stage triple-negative breast cancer: exploration of tumor BRCA mutational status.
- Published in:
- Breast Cancer (13406868), 2024, v. 31, n. 5, p. 886, doi. 10.1007/s12282-024-01603-4
- By:
- Publication type:
- Article
Factors influencing U.S. women's interest and preferences for breast cancer risk communication: a cross-sectional study from a large tertiary care breast imaging center.
- Published in:
- BMC Women's Health, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12905-024-03197-7
- By:
- Publication type:
- Article
Testing Adaptive Therapy Protocols Using Gemcitabine and Capecitabine in a Preclinical Model of Endocrine-Resistant Breast Cancer.
- Published in:
- Cancers, 2024, v. 16, n. 2, p. 257, doi. 10.3390/cancers16020257
- By:
- Publication type:
- Article
Metastatic ER+ Breast Cancer: Mechanisms of Resistance and Future Therapeutic Approaches.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 22, p. 16198, doi. 10.3390/ijms242216198
- By:
- Publication type:
- Article
Genomic analysis of advanced breast cancer tumors from talazoparib-treated gBRCA1/2mut carriers in the ABRAZO study.
- Published in:
- NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00561-y
- By:
- Publication type:
- Article
Neoadjuvant Talazoparib in Patients With Germline BRCA1/2 Mutation-Positive, Early-Stage Triple-Negative Breast Cancer: Results of a Phase II Study.
- Published in:
- Oncologist, 2023, v. 28, n. 10, p. 845, doi. 10.1093/oncolo/oyad139
- By:
- Publication type:
- Article
PARP Inhibitors for Breast Cancer: Germline BRCA1/2 and Beyond.
- Published in:
- Cancers, 2022, v. 14, n. 17, p. 4332, doi. 10.3390/cancers14174332
- By:
- Publication type:
- Article
Personalized Breast Cancer Risk Assessment: Incorporation of Genetic and High-Risk Factors on Breast Cancer Risk and Management.
- Published in:
- Chirurgia, 2021, v. 116, p. S22, doi. 10.21614/chirurgia.116.5.suppl.s22
- By:
- Publication type:
- Article
Relations of Mindfulness and Illness Acceptance With Psychosocial Functioning in Patients With Metastatic Breast Cancer and Caregivers.
- Published in:
- Oncology Nursing Forum, 2020, v. 47, n. 6, p. 739, doi. 10.1188/20.ONF.739-752
- By:
- Publication type:
- Article
Talazoparib in Patients with a Germline BRCA‐Mutated Advanced Breast Cancer: Detailed Safety Analyses from the Phase III EMBRACA Trial.
- Published in:
- Oncologist, 2020, v. 25, n. 3, p. e439, doi. 10.1634/theoncologist.2019-0493
- By:
- Publication type:
- Article
Outcomes in Clinically Relevant Patient Subgroups From the EMBRACA Study: Talazoparib vs Physician's Choice Standard-of-Care Chemotherapy.
- Published in:
- JNCI Cancer Spectrum, 2020, v. 4, n. 1, p. N.PAG, doi. 10.1093/jncics/pkz085
- By:
- Publication type:
- Article
Immunotherapy for the Treatment of Breast Cancer: Emerging New Data.
- Published in:
- Breast Cancer: Targets & Therapy, 2020, v. 12, p. 321, doi. 10.2147/BCTT.S184710
- By:
- Publication type:
- Article
Efficacy/Safety of Talazoparib or Physician's Choice of Therapy in US Patients with HER2-Negative Germline BRCA1/2-Mutated Locally Advanced/Metastatic Breast Cancer (EMBRACA).
- Published in:
- Journal of Oncology Navigation & Survivorship, 2019, v. 10, n. 11, p. 501
- By:
- Publication type:
- Article
Metastatic breast cancer patients' expectations and priorities for symptom improvement.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Mechanisms of resistance to BRAF and MEK inhibitors and clinical update of US Food and Drug Administration-approved targeted therapy in advanced melanoma.
- Published in:
- OncoTargets & Therapy, 2018, v. 11, p. 7095, doi. 10.2147/OTT.S182721
- By:
- Publication type:
- Article
Acceptance and commitment therapy for symptom interference in metastatic breast cancer patients: a pilot randomized trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Altered expression of telomere‐associated genes in leukocytes among BRCA1 and BRCA2 carriers.
- Published in:
- Molecular Carcinogenesis, 2018, v. 57, n. 4, p. 567, doi. 10.1002/mc.22773
- By:
- Publication type:
- Article
Symptom experiences in metastatic breast cancer patients: relationships to activity engagement, value-based living, and psychological inflexibility.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A phase II study of combined VEGF inhibitor (bevacizumab+sorafenib) in patients with metastatic breast cancer: Hoosier Oncology Group Study BRE06-109.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 5, p. 1307, doi. 10.1007/s10637-013-9976-1
- By:
- Publication type:
- Article
Persistent upregulation of U6:SNORD44 small RNA ratio in the serum of breast cancer patients.
- Published in:
- 2011
- By:
- Publication type:
- journal article
A phase II study of oral enzastaurin in patients with metastatic breast cancer previously treated with an anthracycline and a taxane containing regimen.
- Published in:
- Investigational New Drugs, 2009, v. 27, n. 6, p. 565, doi. 10.1007/s10637-009-9220-1
- By:
- Publication type:
- Article
Predicting response to primary chemotherapy: gene expression profiling of paraffin-embedded core biopsy tissue.
- Published in:
- Breast Cancer Research & Treatment, 2007, v. 103, n. 2, p. 197, doi. 10.1007/s10549-006-9366-x
- By:
- Publication type:
- Article
Twenty Years of Systemic Therapy for Breast Cancer.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 14, p. 1833
- By:
- Publication type:
- Article
Twenty Years of Systemic Therapy for Breast Cancer.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 1, p. 25
- By:
- Publication type:
- Article